drugset / Trial / NCT02050893

The Effect of Midazolam on Fluid Responsiveness in Septic Patients

NCT02050893

Phase 1/2 Completed 40 enrolled Southeast University, China
RandomizedParallel-groupOpen-labelTreatment

Summary

Fluid resuscitation remains the foundation for septic treatment.The evaluation of fluid responsiveness has significance in volume resuscitation for septic shock patients. As the sedative which is commonly used in ICU, Midazolam is supposed to change fluid responsiveness for the pharmacological effect of venodilation. However, the hypothesis has not been certified clinically. In this research, the investigators aim to test the hypothesis that Midazolam can increase fluid responsiveness(using passive leg raising test) in septic shock patients.

Timeline

Start
2012-05
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 0.02 mg/kg
Subject Midazolam Small molecule 0.1 mg/kg
Subject Propofol Small molecule 0.5 mg/kg
Subject Propofol Small molecule 2 mg/kg